InMed Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INM and other ETFs, options, and stocks.

About INM

InMed Pharmaceuticals, Inc. engages in the provision of biopharmaceutical research. It operates through the InMed Pharma and BayMedica segments. 

CEO
Eric A. Adams
CEOEric A. Adams
Employees
13
Employees13
Headquarters
Vancouver, British Columbia
HeadquartersVancouver, British Columbia
Founded
1981
Founded1981
Employees
13
Employees13

INM Key Statistics

Market cap
5.18M
Market cap5.18M
Price-Earnings ratio
-0.18
Price-Earnings ratio-0.18
Dividend yield
—
Dividend yield—
Average volume
73.96K
Average volume73.96K
High today
$2.37
High today$2.37
Low today
$2.30
Low today$2.30
Open price
$2.34
Open price$2.34
Volume
60.60K
Volume60.60K
52 Week high
$15.70
52 Week high$15.70
52 Week low
$1.72
52 Week low$1.72

People also own

Based on the portfolios of people who own INM. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
XTI Aerospace, Inc.
Hyperscale Data
Plug Power
FuelCell Energy
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.